Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Inherited risk assessment of prostate cancer: it takes three to do it right

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

References

  1. Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial risk and heritability of cancer among twins in Nordic Countries. JAMA. 2016;315:68–76.

    Article  CAS  Google Scholar 

  2. Xu J, Sun J, Zheng SL. Prostate cancer risk-associated genetic markers and their potential clinical utility. Asian J Androl. 2013;15:314–22.

    Article  CAS  Google Scholar 

  3. National Cancer Institute. The Cancer Data Access System. https://biometry.nci.nih.gov/cdas/. Accessed 24 May 2019.

  4. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, et al. Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012;366:141–9.

    Article  CAS  Google Scholar 

  5. Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016;375:443–53.

    Article  CAS  Google Scholar 

  6. Na R, Zheng SL, Han M, Yu H, Jiang D, Shah S, et al. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death. Eur Urol. 2017;71:740–7.

    Article  CAS  Google Scholar 

  7. Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50:928–36.

    Article  CAS  Google Scholar 

  8. Conran CA, Na R, Chen H, Jiang D, Lin X, Zheng SL, et al. Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer. Asian J Androl. 2016;18:520–4.

    Article  CAS  Google Scholar 

  9. Yu H, Shi Z, Wu Y, Wang C-H, Lin X, Perschon C, et al. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values. Prostate. 2019;79:1099–105.

    Article  Google Scholar 

  10. Chen H, Liu X, Brendler CB, Ankerst DP, Leach RJ, Goodman PJ, et al. Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: results from the prostate cancer prevention trial. Prostate. 2016;76:1120–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jianfeng Xu or Brian T. Helfand.

Ethics declarations

Conflict of interest

JX and WI hold an issued US patent “Methods and compositions for correlating genetic markers with PCa risk” (US9732389 B2). The remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Labbate, C.V., Isaacs, W.B. et al. Inherited risk assessment of prostate cancer: it takes three to do it right. Prostate Cancer Prostatic Dis 23, 59–61 (2020). https://doi.org/10.1038/s41391-019-0165-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-019-0165-y

This article is cited by

Search

Quick links